Page 264 | ASweetLife

Long Term Use of Diabetes Drug Actos May Increase Risk of Cancer

The U.S. Food and Drug Administration (FDA) issued a safety announcement informing the public that use of the type 2 diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer. Information about this risk will be added to the Warnings and Precautions section of the label for pioglitazone-containing medicines. The patient Medication Guide for these medicines...

A Vampire’s Dessert

In a recent daydream I attended a conference on canine diabetes at the Cummings School of Veterinary Medicine at Tufts University. While there…

Running and Pumping for the First Time

When I woke up Tuesday morning with my blood sugar at 99 I was pleased and felt that I had made the right decision giving up insulin shots and getting…

New Type 2 Diabetes Treatment Tradjenta Now Available in U.S. Pharmacies

The new type 2 diabetes drug Tradjenta (linagliptin) is now available by prescription in pharmacies across the United States including Walgreens, CVS, Rite Aid following the U.S. Food and Drug Administration (FDA) approval of the drug on May 2, 2011. Tradjenta was approved as a prescription medication to be used along with diet and exercise to lower blood sugar in adults with type 2 diabetes...

Hooking up

Monday morning started like most Monday mornings. I woke up at 4:20 a.m. and was out the door at 5:15 a.m. to meet my running group. We ran hills and…

Sweet Blood

In the morning, I think of my father. Perhaps only for a moment, and perhaps it is not so much a thought as an evocation, an impression. But he is there with me in the bathroom there in the cool bottle of insulin, snug in my hand like an egg in a nest...

Novo Nordisk Issues Letter Reminding Healthcare Professionals of Victoza Risks

Novo Nordisk issued a letter reminding healthcare professionals of important safety information about the type 2 diabetes drug Victoza (liraglutide [rDNA origin]). The letter was issued because a recent assessment of healthcare providers showed that some primary care providers are not fully aware of the serious risks associated with the use of Victoza...